Wing-KinSynMDPhD, FEBGH, FACP, FRCPE, FRCP
Gastroenterology • Saint Louis, MOHepatology & Liver Transplantation
James F King Chair in Gastroenterology / Director, Division of Gastroenterology and Hepatology / Co-Director, Saint Louis University Liver Center / Co-Executive Director, Metabolic & Nutrition Institute / Professor of Medicine / Research Track Fellowship Director / Physician-Scientist / Attending Physician
Dr. Syn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1008 South Spring Avenue
SLUCare Academic Pavilion, 2nd Floor
Saint Louis, MO 63110Phone+1 314-977-2171
Education & Training
University of Sheffield School of MedicineClass of 1998
Certifications & Licensure
MO State Medical License 2021 - 2025
SC State Medical License 2015 - 2022
Clinical Trials
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2016 Mar 01
- Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension Start of enrollment: 2016 Oct 17
- Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Start of enrollment: 2017 Aug 30
Publications & Presentations
PubMed
- Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH.Jason D Coombes, Paul P Manka, Marzena Swiderska-Syn, Danielle T Vannan, Antonio Riva
Liver International. 2025-04-01 - Low prevalence of peptic ulcer disease in hospitalized patients with cystic fibrosis: A national database study.Maya Mahmoud, Eugene Nwankwo Jr, Zidong Zhang, Neel Matiwala, Rohan Tripathi
The American Journal of the Medical Sciences. 2025-03-01 - Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two target...Eda Kaya, Wing-Kin Syn, Paul Manka
Current Opinion in Gastroenterology. 2025-02-14
Committees
- NASH Council Member, Global Liver Institute 2018 - Present
- Committee Member, National VA NAFLD Strategic Planning Committee 2019 - 2021
- Education Steering Committee, AASLD Liver Fibrosis SIG 2018 - 2020
- Member, RHJ VAMC R&D Committee 2016 - 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
